|
SETDB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.961100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.538000E-03 |
| Normal-vs-Stage2 |
2.920200E-01 |
| Normal-vs-Stage3 |
5.546200E-02 |
| Normal-vs-Stage4 |
7.63220000000731E-05 |
| Stage1-vs-Stage2 |
5.159200E-01 |
| Stage1-vs-Stage3 |
6.710400E-01 |
| Stage1-vs-Stage4 |
5.404200E-02 |
| Stage2-vs-Stage3 |
4.303200E-01 |
| Stage2-vs-Stage4 |
2.206300E-02 |
| Stage3-vs-Stage4 |
7.191900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.880000E-03 |
| Normal-vs-AfricanAmerican |
1.021420E-01 |
| Normal-vs-Asian |
7.344000E-02 |
| Caucasian-vs-AfricanAmerican |
5.024000E-01 |
| Caucasian-vs-Asian |
6.907000E-01 |
| AfricanAmerican-vs-Asian |
5.734400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.977890E-03 |
| Normal-vs-Female |
1.752390E-01 |
| Male-vs-Female |
2.293200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.747900E-02 |
| Normal-vs-Extreme_Weight |
1.363500E-03 |
| Normal-vs-Obese |
2.014000E-02 |
| Normal-vs-Extreme_Obese |
6.456800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.999400E-01 |
| Normal_Weight-vs-Obese |
9.975400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.014200E-01 |
| Extreme_Weight-vs-Obese |
3.319000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.943850E-01 |
| Obese-vs-Extreme_Obese |
4.971600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.775800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.093570E-01 |
| Normal-vs-Age(61-80Yrs) |
1.124070E-03 |
| Normal-vs-Age(81-100Yrs) |
1.559100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.940200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.284400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.983400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.835600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.216400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.971200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.221600E-04 |
| Normal-VS-Type2 PRCC |
4.040200E-02 |
| Normal-VS-KIRP CIMP |
1.64209978947838E-10 |
| Normal-VS-Unclassified PRCC |
7.215400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.291000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.15190000052834E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
6.412200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.72200000504131E-08 |
| Type2 PRCC-VS-Unclassified PRCC |
1.341840E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.51104999999152E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.607600E-02 |
| Normal-vs-N1 |
1.021210E-03 |
| Normal-vs-N2 |
4.372100E-04 |
| N0-vs-N1 |
2.091200E-01 |
| N0-vs-N2 |
3.971600E-04 |
| N1-vs-N2 |
1.892640E-01 |
|
|
